Industry / innovation partners

AI Pathology Starts Moving Toward Treatment Selection

Hepatitis B Functional Cure Moves Closer, But Access Still Starts With Diagnosis

Huntington’s Disease Gets an Oral Target-Engagement Signal

A Urine Test for Alzheimer’s Would Change the Access Conversation

AI Multiomics Moves Into the Trial Stratification Layer

A New CELMoD Raises the Bar in Relapsed Myeloma
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
